Jiangsu Bioperfectus Technologies Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Jiangsu Bioperfectus Technologies Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.00 Million ≈ $2.93 Million USD) by net assets (CN¥2.97 Billion ≈ $434.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

Cash flow conversion efficiency of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688399 stock price and chart for real-time trading data and today's change.

Jiangsu Bioperfectus Technologies Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Bioperfectus Technologies Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Bioperfectus Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their cash flow conversion efficiency. Also see 688399 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shanxi C&Y Pharmaceutical Group Co Ltd SHE:300254	0.100x
Brooge Holdings Ltd NASDAQ:BROG	0.273x
Envipco Holding N.V. AS:ENVI	0.047x
G Willi-Food International Ltd TA:WILC	0.026x
Jiangsu Safety Wire Rope SHG:603028	0.047x
Eastern Pioneer Auto Driving S SHG:603377	0.177x
Vista Gold Corporation NYSE MKT:VGZ	-0.036x
F-SECURE OYJ HE:FSECURE	0.094x

Annual Cash Flow Conversion Efficiency for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. Review cash generation quality of Jiangsu Bioperfectus Technologies Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.25 Billion ≈ $475.67 Million	CN¥145.93 Million ≈ $21.35 Million	0.045x	+235.10%
2023-12-31	CN¥3.41 Billion ≈ $498.27 Million	CN¥-113.14 Million ≈ $-16.56 Million	-0.033x	-106.39%
2022-12-31	CN¥3.78 Billion ≈ $552.86 Million	CN¥1.96 Billion ≈ $287.52 Million	0.520x	+33.85%
2021-12-31	CN¥2.54 Billion ≈ $371.16 Million	CN¥985.52 Million ≈ $144.21 Million	0.389x	-30.90%
2020-12-31	CN¥1.66 Billion ≈ $243.57 Million	CN¥935.88 Million ≈ $136.95 Million	0.562x	+437.82%
2019-12-31	CN¥1.02 Billion ≈ $149.37 Million	CN¥106.72 Million ≈ $15.62 Million	0.105x	-60.52%
2018-12-31	CN¥324.10 Million ≈ $47.43 Million	CN¥85.82 Million ≈ $12.56 Million	0.265x	+11.90%
2017-12-31	CN¥260.28 Million ≈ $38.09 Million	CN¥61.59 Million ≈ $9.01 Million	0.237x	+169.80%
2016-12-31	CN¥251.90 Million ≈ $36.86 Million	CN¥22.09 Million ≈ $3.23 Million	0.088x	--

About Jiangsu Bioperfectus Technologies Co Ltd

SHG:688399 China Biotechnology

Market Cap

$284.86 Million

CN¥1.95 Billion CNY

Market Cap Rank

#14756 Global

#4365 in China

Share Price

CN¥23.21

Change (1 day)

-2.89%

52-Week Range

CN¥21.80 - CN¥84.90

All Time High

CN¥419.88